301 related articles for article (PubMed ID: 16140565)
1. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model.
Dube A; Sharma S; Gupta PK
Oral Oncol; 2006 Jan; 42(1):77-82. PubMed ID: 16140565
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic treatment of oral squamous cell carcinoma in hamster cheek pouch model using chlorin p6-histamine conjugate.
Parihar A; Dube A; Gupta PK
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):79-86. PubMed ID: 23465376
[TBL] [Abstract][Full Text] [Related]
3. Tumor regression induced by photodynamic treatment with chlorin p(6) in hamster cheek pouch model of oral carcinogenesis: Dependence of mode of tumor cell death on the applied drug dose.
Dube A; Sharma S; Gupta PK
Oral Oncol; 2011 Jun; 47(6):467-71. PubMed ID: 21550293
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
6. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration.
Yoshida T; Tokashiki R; Ito H; Shimizu A; Nakamura K; Hiramatsu H; Tsukahara K; Shimizu S; Takata D; Okamoto I; Suzuki M
Auris Nasus Larynx; 2008 Dec; 35(4):545-51. PubMed ID: 18242905
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
11. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Peng Q; Moan J; Ma LW; Nesland JM
Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
[TBL] [Abstract][Full Text] [Related]
12. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068
[TBL] [Abstract][Full Text] [Related]
13. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch precancerous lesions by topical photosan-mediated photodynamic therapy.
Chiang CP; Huang WT; Lee JW; Hsu YC
Head Neck; 2012 Apr; 34(4):505-12. PubMed ID: 21484926
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of chlorin p(6) to histamine enhances its cellular uptake and phototoxicity in oral cancer cells.
Parihar A; Dube A; Gupta PK
Cancer Chemother Pharmacol; 2011 Aug; 68(2):359-69. PubMed ID: 20978762
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD-S31.
Date M; Sakata I; Fukuchi K; Ohura K; Azuma Y; Shinohara M; Matsuzaki K; Namiki Y; Takahashi H
Lasers Surg Med; 2003; 33(1):57-63. PubMed ID: 12866122
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]